The Interplay Between Gut Microbiota, Adipose Tissue, and Migraine: A Narrative Review

Valentina Biagioli1, Federica Mela2, Paola Ferraro2

  • 1Department of Neurosciences, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health, University of Genoa, 16126 Genoa, Italy.

Nutrients
|January 25, 2025
PubMed
Abstract

Insights

Migraine may be influenced by gut bacteria and body fat. Targeting the gut-brain axis and adipose tissue with diet and supplements shows promise for managing migraine.

Area of Science:

  • Neuroscience
  • Microbiology
  • Metabolic Science

Background:

  • Migraine is a common neurovascular disorder with substantial global impact.
  • Gut microbiota and adipose tissue are increasingly recognized as key modulators of migraine pathophysiology.
  • Mechanisms involve neuroinflammation and metabolic dysregulation.

Purpose of the Study:

  • To review the current literature on the interplay between gut microbiota, adipose tissue, and migraine.
  • To explore the role of dietary interventions in modulating these relationships.
  • To synthesize findings on the gut-brain axis in migraine.

Main Methods:

  • A narrative review of studies published between 2000 and 2024.
  • Literature search conducted using the PubMed database.
  • Analysis of studies examining microbiota, adipose tissue, and migraine, including dietary impacts.

Main Results:

  • A bidirectional gut-brain axis exists, with gut microbiota influencing neuroinflammation via metabolites like short-chain fatty acids (SCFAs).
  • Obesity worsens migraine through chronic inflammation and dysregulated adipocytokines (leptin, adiponectin).
  • Dietary patterns (low glycemic index, Mediterranean) and microbial interventions (prebiotics, probiotics, postbiotics) show therapeutic potential.

Conclusions:

  • Integrative therapeutic strategies targeting the microbiota-gut-brain axis and adipose tissue are crucial for migraine management.
  • Future research should focus on longitudinal studies and personalized interventions for optimized migraine treatment outcomes.